名稱 | FCGR2B/HEK293 |
型號(hào) | CBP74078 |
報(bào)價(jià) | ![]() |
特點(diǎn) | FCGR2B/HEK293,凍存條件:90% FBS+10% DMSO |
產(chǎn)品搜索
相關(guān)文章
- PNAS:腫瘤細(xì)胞或可“拆用”間充質(zhì)干細(xì)胞來促進(jìn)乳腺癌復(fù)發(fā)
- MYC診斷標(biāo)準(zhǔn)品
- IHC第三方質(zhì)控品——病理質(zhì)控基石,精準(zhǔn)診斷起點(diǎn)
- 腫瘤免疫藥靶細(xì)胞模型系列——LAG3
- 【基因編輯產(chǎn)品新品上市】MET Ex14 skipping新添成員
- 假病毒標(biāo)準(zhǔn)品
- 腸道守護(hù)者--GLP2R
- eLife:為何肺癌靶向治療會(huì)失敗?看看科學(xué)家們?cè)趺凑f
- 【連載-企業(yè)參考品】 神經(jīng)膠質(zhì)瘤的診斷參考品的選擇
- 從《指導(dǎo)原則》中分析參考品盤設(shè)計(jì)
聯(lián)系我們
聯(lián)系人:蔣經(jīng)理
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > 腫瘤免疫細(xì)胞株 > CBP74078FCGR2B/HEK293

- 詳細(xì)內(nèi)容
CBP74078 | |
I. Background | |
The protein encoded by this gene is a low affinity receptor for the Fc region of immunoglobulin gamma complexes. The encoded protein is involved in the phagocytosis of immune complexes and in the regulation of antibody production by B-cells. Variations in this gene may increase susceptibilty to systemic lupus erythematosus (SLE). Several transcript variants encoding different isoforms have been found for this gene. | |
II. Description | |
Recombinant HEK293 cells constitutively expressing human FCGR2B. | |
III. Introduction | |
Host Cell: | HEK293 |
Expressed gene: | FCGR2B(FcγRIIb) |
Stability: | 32 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Synonym(s): | CD32B, FCG2, Fc gamma receptor, Fcgamma receptor |
Freeze Medium: | 90% FBS+10% DMSO |
Culture Medium: | DMEM +10%FBS+100ug/ml Hygromycin B |
Mycoplasma Testing: | Negative |
Storage: | Liquid nitrogen |
Application(s): | Binding Assay,FACS |
IV. Description of Host Cell Line | |
Organism: | Human |
Tissue: | kidney |
Morphology: | Epitheloid cell |
Growth Properties: | Adherent |
Ⅴ. Representative Data | |
Figure 1.Recombinant HEK293 cells constitutively expressing FCGR2B(FcγRIIb). | |